RCE

RECCE PHARMACEUTICAL

0.66

-0.01-2.24%

Closed16:10 01/09 AEDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE0.670/0.670

TODAY RANGE0.650-0.675

VOL206.81K

MARKET CAP189.42M

52 WEEK RANGE0.275-0.680

AVG VOL (3M)183.69K

% TURNOVER0.07%

TURNOVER137.06K

P/E (TTM)-7.2456

% RANGE3.73%

EPS(TTM)-0.0904

P/E(FORWARD)-8.9116

P/B-61.7925

BVPS-0.0106

DIVIDEND--

P/S24.53

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP108.07M

SHARES OUTSTANDING289.18M

NEXT EARNINGS02/26-03/02

FREE FLOAT164.99M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

ASX·5d ago
corporate presentation
ASX·12/15/2025 22:51
RCE Awarded Advanced Overseas Finding up to A$85m
ASX·12/02/2025 00:00
corporate presentation
ASX·11/26/2025 23:07
Hong Kong Patent Granted for RECCE Anti-Infectives
ASX·11/25/2025 22:52
Positive Efficacy Data for Inhaled R327 in HAP/VAP Model
ASX·11/14/2025 05:10
Passing of Dr Graham Melrose - Recce founder and inventor
ASX·11/11/2025 00:00
Company Conference Presentation
ASX·11/05/2025 03:11
Results of Meeting
ASX·11/04/2025 22:01
AGM Presentation
ASX·10/31/2025 06:23
Quarterly Activities/Appendix 4C Cash Flow Report
ASX·10/14/2025 07:24
Change of Director's Interest Notices
ASX·10/08/2025 00:00
Update - Notification of buy-back - RCE
ASX·10/07/2025 21:35
Notification of cessation of securities - RCE
ASX·10/03/2025 01:56
Notice of Annual General Meeting/Proxy Form

Same Industry

Name/Symbol

Change%

Price

No data yet, let's see others

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.